PVI
SOPH icon

Pura Vida Investments’s SOPHiA GENETICS SOPH Stock Holding History

Pura Vida Investments’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-284,724
Closed -$1.34M – 68
2023
Q4 		$1.34M Hold
284,724
– – 0.2% 40
2023
Q3 		$725K Sell
284,724
-324,777
-53% -$1.03M 0.14% 75
2023
Q2 		$2.73M Sell
609,501
-238,769
-28% -$1.08M 0.36% 57
2023
Q1 		$4.22M Buy
848,270
+94,234
+12% +$305K 0.43% 52
2022
Q4 		$1.55M Sell
754,036
-142,204
-16% -$319K 0.08% 131
2022
Q3 		$2.36M Buy
896,240
+36,310
+4% +$127K 0.14% 124
2022
Q2 		$3.11M Buy
859,930
+30,000
+4% +$152K 0.18% 114
2022
Q1 		$6.42M Buy
+829,930
New +$9.32M 0.21% 108
2021
Q4 		– Sell
-450,010
Closed -$7.89M – 304
2021
Q3 		$7.89M Buy
+450,010
New +$7.91M 0.24% 115

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Pura Vida Investments's SOPH Position: Q1 2024 in Review

Pura Vida Investments sold out of SOPHiA GENETICS (SOPH) in Q1 2024, closing a stake of 284,724 shares — an estimated $1.34M sold.

Pura Vida Investments first reported a position in SOPH in Q3 2021 and held it in 9 quarters. The position peaked at $7.89M in Q3 2021. 32 funds tracked by Wall St. Rank hold SOPH as of Q1 2024.

  • Pura Vida Investments reported no remaining SOPHiA GENETICS position as of Q1 2024 after selling out during the quarter.
  • Pura Vida Investments sold 284,724 SOPHiA GENETICS shares in Q1 2024, an estimated $1.34M.
  • Pura Vida Investments first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 9 quarters.
  • Pura Vida Investments's SOPHiA GENETICS position peaked at $7.89M in Q3 2021.
  • 32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2024.

Based on Pura Vida Investments's 13F filing for Q1 2024, filed 15 May 2024.